Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ube's change in receivables for the quarter that ended in Mar. 2026 was $-118 Mil. It means Ube's Accounts Receivable
increased by $118 Mil
from Dec. 2025 to Mar. 2026 .
Ube's change in receivables for the fiscal year that ended in Mar. 2026 was $90 Mil. It means Ube's Accounts Receivable
declined by $90 Mil
from Mar. 2025 to Mar. 2026 .
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Ube's Days Sales Outstanding for the
three
months ended in Mar. 2026 was 67.84.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Ube's liquidation value for the
three
months ended in Mar. 2026 was $-1,856 Mil.
Ube (OTCPK:UBEOF) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Ube's Days Sales Outstanding for the quarter that ended in Mar. 2026 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ube Change In Receivables Related Terms
Ube Change In Receivables Historical Data
* Premium members only.
The historical data trend for Ube's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $103 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Change In Receivables of $103 Mil mean?
Ube (UBEOF) has a Change In Receivables of $103 Mil as of Mar. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Ube and its competitors.
Is Ube's Change In Receivables too high?
Ube's current Change In Receivables is $103 Mil. Overall, Ube has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Ube's Change In Receivables compare to LIN and SHW?
Ube's Change In Receivables of $103 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Chemicals company?
A good Change In Receivables depends on the Chemicals industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Ube and its competitors. Ube's current Change In Receivables is $103 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ube stock overvalued right now?
Ube (UBEOF) has a current Change In Receivables of $103 Mil. The stock's GF Value™ is $11.04, compared to a current price of $15.29 — trading 38.5% above its estimated fair value. The current Change In Receivables is $103 Mil. Ube's overall GF Score™ is 59/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Ube (UBEOF), the current Change In Receivables is $103 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ube (UBEOF) Overvalued in 2026?
Based on GuruFocus' analysis, Ube stock appears to be overvalued.
The current stock price of $15.29 is trading 38.5% above its estimated GF Value™ of $11.04.
Key valuation signals for UBEOF:
Change In Receivables: $103 Mil
GF Value™: $11.04 vs. price of $15.29 (38.5% above fair value)
No single metric tells the full story. See the UBEOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ube Corp manufactures and sells chemicals, construction materials, and machinery products. The firm organizes itself into five segments based on product type. The chemicals segment, which generates more revenue than any other segment, sells a variety of chemicals including resins, rubber, silicon, and plastics. The cement and construction segment sells cement, plaster, and foundation materials to the construction and building industries. The pharmaceutical segment sells anti-allergic, anti-hypertensive, and anti-platelet drugs. The machinery and metal products segment sells die-casting and electric injection machines. The energy and environment segment generates electricity from coal and biomass. The majority of revenue comes from Japan.
59GF Score
Get the complete analysis for UBEOF
Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
UBEOF has been successfully added to your 
